Tag

After a brief slowdown in 2021, shareholder activism has made a strong resurgence in 2022-23, with many new players and increased investments opportunities driven by depressed equity values. The panel will discuss the regulatory environment, SEC rules and regulations, universal...

M&A activity is still significantly above pre-pandemic levels, with healthcare remaining one of the most active industries transactionally. The panel will discuss M&A trends by healthcare verticals, labor and supply chain shortages, financing availability, valuations and...

REGISTER COMPLIMENTARY / SUBMIT QUESTIONS TO THE PANEL HERE